Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Biol Chem ; 290(29): 18237-18244, 2015 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-26055705

RESUMO

Class IIa histone deacetylases repress transcription of target genes. However, their mechanism of action is poorly understood because they exhibit very low levels of deacetylase activity. The class IIa HDACs are associated with the SMRT/NCoR repression complexes and this may, at least in part, account for their repressive activity. However, the molecular mechanism of recruitment to co-repressor proteins has yet to be established. Here we show that a repeated peptide motif present in both SMRT and NCoR is sufficient to mediate specific interaction, with micromolar affinity, with all the class IIa HDACs (HDACs 4, 5, 7, and 9). Mutations in the consensus motif abrogate binding. Mutational analysis of HDAC4 suggests that the peptide interacts in the vicinity of the active site of the enzyme and requires the "closed" conformation of the zinc-binding loop on the surface of the enzyme. Together these findings represent the first insights into the molecular mechanism of recruitment of class IIa HDACs to the SMRT/NCoR repression complexes.


Assuntos
Histona Desacetilases/metabolismo , Correpressor 2 de Receptor Nuclear/metabolismo , Sequência de Aminoácidos , Domínio Catalítico , Histona Desacetilases/química , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Correpressor 2 de Receptor Nuclear/química , Domínios e Motivos de Interação entre Proteínas , Mapas de Interação de Proteínas , Proteínas Repressoras/química , Proteínas Repressoras/metabolismo
2.
Artigo em Inglês | MEDLINE | ID: mdl-21206028

RESUMO

The genome of the enteric pathogen Campylobacter jejuni encodes a single glyceraldehyde-3-phosphate dehydrogenase that can utilize either NADP+ or NAD+ as coenzymes for the oxidative phosphorylation of glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate. Here, the cloning, expression, purification, crystallization and preliminary X-ray analysis of both the wild type and an active-site mutant of the enzyme are presented. Preliminary X-ray analysis revealed that in both cases the crystals diffracted to beyond 1.9 Šresolution. The space group is shown to be I4(1)22, with unit-cell parameters a=90.75, b=90.75, c=225.48 Å, α=90.46, ß=90.46, γ=222.79°; each asymmetric unit contains only one subunit of the tetrameric enzyme.


Assuntos
Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Campylobacter jejuni/enzimologia , Gliceraldeído-3-Fosfato Desidrogenases/química , Gliceraldeído-3-Fosfato Desidrogenases/genética , Proteínas de Bactérias/isolamento & purificação , Domínio Catalítico , Clonagem Molecular , Cristalização , Cristalografia por Raios X , Gliceraldeído-3-Fosfato Desidrogenases/isolamento & purificação , Humanos , Dados de Sequência Molecular
3.
Cell Rep ; 16(11): 2802-2810, 2016 09 13.
Artigo em Inglês | MEDLINE | ID: mdl-27626651

RESUMO

Drugs that recapitulate aspects of the exercise adaptive response have the potential to provide better treatment for diseases associated with physical inactivity. We previously observed reduced skeletal muscle class IIa HDAC (histone deacetylase) transcriptional repressive activity during exercise. Here, we find that exercise-like adaptations are induced by skeletal muscle expression of class IIa HDAC mutants that cannot form a corepressor complex. Adaptations include increased metabolic gene expression, mitochondrial capacity, and lipid oxidation. An existing HDAC inhibitor, Scriptaid, had similar phenotypic effects through disruption of the class IIa HDAC corepressor complex. Acute Scriptaid administration to mice increased the expression of metabolic genes, which required an intact class IIa HDAC corepressor complex. Chronic Scriptaid administration increased exercise capacity, whole-body energy expenditure and lipid oxidation, and reduced fasting blood lipids and glucose. Therefore, compounds that disrupt class IIa HDAC function could be used to enhance metabolic health in chronic diseases driven by physical inactivity.


Assuntos
Proteínas Correpressoras/metabolismo , Metabolismo Energético , Histona Desacetilases/metabolismo , Metabolismo dos Lipídeos , Animais , Domínio Catalítico , Linhagem Celular , Metabolismo Energético/efeitos dos fármacos , Metabolismo Energético/genética , Regulação da Expressão Gênica/efeitos dos fármacos , Hidroxilaminas/administração & dosagem , Hidroxilaminas/farmacologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Metabolismo dos Lipídeos/genética , Fatores de Transcrição MEF2/genética , Fatores de Transcrição MEF2/metabolismo , Camundongos , Mutação/genética , Oxirredução , Condicionamento Físico Animal , Ligação Proteica/efeitos dos fármacos , Quinolinas/administração & dosagem , Quinolinas/farmacologia , Transcrição Gênica/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA